Hester Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 0.50 M
as on 05-07-2024
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.01 Cr
as on 05-07-2024
- Satisfied Charges ₹ 3.84 Cr
as on 05-07-2024
- Revenue 6.06%
(FY 2023)
- Profit -0.22%
(FY 2023)
- Ebitda -1.36%
(FY 2023)
- Net Worth 15.49%
(FY 2023)
- Total Assets 8.66%
(FY 2023)
About Hester Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹8.01 Cr. The company has closed loans amounting to ₹3.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Gandhi, Hetal Gandhi, Nina Gandhi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85195MH1998PTC115289
- Company No.
115289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 1998
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hester Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Gandhi  | Director | 09-Jun-1998 | Current |
| Hetal Gandhi | Director | 09-Jun-1998 | Current |
| Nina Gandhi | Director | 09-Jun-1998 | Current |
| Sanjiv Gandhi | Director | 09-Jun-1998 | Current |
Financial Performance and Corporate Structure Insights of Hester Diagnostics.
Hester Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.06% increase. The company also saw a slight decrease in profitability, with a 0.22% decrease in profit. The company's net worth Soared by an impressive increase of 15.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hester Diagnostics?
In 2023, Hester Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hester Biosciences LimitedActive 37 years 7 monthsRajiv Gandhi, Nina Gandhi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Aug 2022 | ₹5.14 M | Open |
Others Creation Date: 03 Apr 2002 | ₹7.50 Cr | Open |
Central Bank Of India Creation Date: 28 Sep 2013 | ₹3.15 Cr | Satisfied |
How Many Employees Work at Hester Diagnostics?
Unlock and access historical data on people associated with Hester Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hester Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hester Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
